India Breast Lesion Localization Methods Market

Market Overview

The India breast lesion localization methods market size has witnessed significant growth in the past and is expected to grow at a CAGR of 18.8% during the forecast period (2022-2031).

The acceptance and usage of breast lesion localization methods, including MRI, ultrasound, and mammography, is contingent upon the healthcare infrastructure of the specific healthcare systems.

Market Dynamics

India Breast Lesion Localization Methods and Market Drivers

Growing Presence of Breast Cancer in the Population

The changing market dynamics and the rise of IT companies have influenced people's priorities, leading to a decreased emphasis on physical well-being. This is evident in the widespread adoption of sedentary lifestyles, particularly among working women who prioritize convenience over healthy cooking and opt for high-calorie packaged and fast-food choices. These dietary shifts have contributed significantly to the rising issue of obesity, a major factor in the increasing occurrence of breast cancer. Moreover, increased alcohol consumption has further exacerbated the prevalence of this disease.

India Breast Lesion Localization Methods Market Restraint

Deficiency in Healthcare Infrastructure for Cancer Care

The sufficient availability of skilled oncologists plays a vital role in effectively diagnosing, treating, and caring for cancer patients. However, there is a notable scarcity of highly competent oncologists capable of providing comprehensive and top-notch care. Additionally, the accessibility of advanced localization technology is limited to developed countries due to inadequate healthcare infrastructure in other regions. Furthermore, numerous hospitals offering oncology services lack the essential equipment and technologies required for accurate diagnosis and treatment of breast cancer.

India Breast Lesion Localization Methods Market Opportunities

Lucrative Growth Prospects in Economically Developing Regions

The rapid urbanization in these countries has resulted in a significant urban population increase, leading to a demand for expanded healthcare infrastructure from both government and private sectors. Our research indicates that government hospitals in these regions lack technology and resources, driving private hospitals to invest heavily in advanced equipment to attract patients and exploit the gaps in public healthcare services. Moreover, governments are incentivizing the establishment of new hospitals through measures such as affordable or free land, patient-focused incentives, treatment cost subsidies, and easy access to loans for purchasing machinery. As a result, many private players are constructing new hospitals and expanding their networks to strengthen their brand presence and market position.

Regional Analysis

The breast lesion localization methods market in India shows promising growth prospects. With a rising prevalence of breast cancer cases and increasing awareness about early detection, there is a growing demand for localization methods such as mammography, ultrasound, and MRI. However, limited access to advanced healthcare infrastructure and affordability concerns pose challenges to market expansion.

Segmental Analysis

The India breast lesion localization methods market is segmented into type and usage.

By type, it is further segmented into wire localization, radioisotope localization, magnetic localization, and others.

Wire localization dominated the market and is expected to register a CAGR of 19.2% over the forecast period. Wire localization is used to identify the lesion's exact location, which aids the surgeon in detecting and removing breast lesions without difficulty if the X-ray detects multiple lesions. This method removes lesions or tumors that are difficult to locate and cannot be felt. In addition, it can be used to remove the smallest possible area, which would be difficult for the surgeon to do without causing visible harm to the surrounding tissue. Some women may experience vertigo or pressure during the painless procedure.

It is further segmented based on usage into tumor identification and sentinel lymph node identification.

Tumor identification dominated the market and is expected to register a CAGR of 18.4% over the forecast period. A triple test is administered for tumor identification, including a physical examination, breast imaging, mammography, and a biopsy. The majority of patients are breast cancer patients. Mammography involves using X-rays to image a breast region containing a tumor. Other imaging technologies, such as MRI and ultrasound, are also employed. Ultrasound is predominantly recommended for women under 30 years old.

Recent Developments

• January 2021: Hologic, Inc., an innovative medical technology company focused on improving women’s health, announced and completed the acquisition of SOMATEX Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately USD 64 million. The company was previously owned by E-Med Solutions GmbH, Berlin, a group of investors led by German private equity company Westlake Partners.